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AIM: To evaluate spinal magnetic resonance imaging (MRI) examinations using a combination of two-dimensional (2D) and three-dimensional (3D) MRI sequences for diagnosis of
drop metastases.
MATERIALS AND METHODS: Fifty-ﬁve paediatric patients with primary brain tumours
were evaluated for drop metastases at initial presentation using spinal MRI including sagittal
2D T1-weighted (W) contrast-enhanced (þC), axial 3D T1WþC volumetric interpolated breathhold (VIBE), and sagittal 3D T2W SPACE (Sampling Perfection with Application optimised
Contrasts using different ﬂip angle Evolutions).
RESULTS: The MRI false-negative rate was 4%, and cerebrospinal ﬂuid (CSF) false-negative
rate was 16% (p¼0.07). The 3D T1WþC VIBE increased the number of drop metastases
detected in 42% of patients. Drop metastases were more conspicuous in 25% of patients on 3D
T2W SPACE.
CONCLUSION: Spinal MRI examinations including 2D and 3D sequences demonstrate characteristics that may improve radiological diagnosis of drop metastases.
Ó 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Introduction
Paediatric brain tumours may disseminate via the cerebrospinal ﬂuid (CSF) into the spinal canal, resulting in
leptomeningeal drop metastases. Accurate diagnosis of
drop metastases is critical for determining prognosis and
directing proper treatment regimens in paediatric brain
tumours, including medulloblastoma.1 Consequently, mischaracterising the absence or presence of drop metastases
* Guarantor and correspondent: S. F. Kralik, Department of Radiology and
Imaging Sciences, Indiana University School of Medicine, 714 N. Senate Ave.,
Indianapolis, Indiana, 46202, USA. Tel.: þ1 (317) 963 7121; fax: þ1 (317) 948
8383.
E-mail address: steve.kralik@gmail.com (S.F. Kralik).

directly affects patient care, potentially resulting in either
inadequate or excessive treatment of disease.
Currently, CSF cytology and spinal MRI are the tests of
choice for the detection of leptomeningeal drop metastases.
Unfortunately, neither of these tests have perfect diagnostic
accuracy.2e4 Current limitations of spinal MRI that may
contribute to indeterminate or inaccurate detection of drop
metastases include technical artefacts (e.g., CSF ﬂow artefacts) and suboptimal spatial resolution. Improvements in
spinal MRI techniques that limit CSF ﬂow artefacts or
improve detection of small tumour deposits, therefore,
would be expected to improve the overall accuracy in
detecting drop metastases.
3D MRI sequences have been developed that signiﬁcantly
decrease CSF ﬂow artefacts, improve the contrast between

http://dx.doi.org/10.1016/j.crad.2017.04.016
0009-9260/Ó 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
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the CSF and spinal cord, and utilize thinner section thickness, all without signiﬁcantly lengthening imaging time.
One such three-dimensional (3D) T1-weighted (W)
contrast-enhanced (þC) MRI sequence is the volumetric
interpolated breath-hold (VIBE) sequence, which allows
thin section imaging with reduced CSF ﬂow artefacts.5
Similar MRI sequences include T1W high resolution
isotropic volume examination (THRIVE) or liver acquisition
with volume acceleration (LAVA). Another 3D T2W
sequence that demonstrates improved visualisation of small
structures in the CSF within the spinal canal is the T2W
Sampling Perfection with Application optimised Contrasts
using different ﬂip angle Evolutions (SPACE) sequence.6
Similar MRI sequences include volume isotropic turbo spin
echo acquisition (VISTA) or CUBE. Because leptomeningeal
drop metastases occur along the surface of the spinal cord, a
3D sequence would theoretically possess an advantage in
accurate detection of drop metastases; however, to the authors’ knowledge, 3D sequences have not been speciﬁcally
evaluated in this regard. The purpose of this research was to
evaluate the performance of spinal MRI, including a combination of 2D and 3D MRI sequences, for the radiological
diagnosis of drop metastases among paediatric patients
with primary brain tumours on initial presentation.

Materials and methods
Following institutional review board approval, a retrospective search from 1 January 2011 to 6 January 2015
identiﬁed a total of 55 paediatric patients (deﬁned as age
18 years) with a primary brain tumour who underwent an
MRI of the entire spine with axial 3D T1WþC VIBE and
sagittal 3D T2W SPACE for detection of drop metastases on
initial presentation prior to any surgical intervention and
who had CSF cytology obtained within 4 weeks of the spine
MRI. Therefore, patients were excluded if no CSF cytology
was obtained; if CSF cytology was obtained >4 weeks from
the total spine MRI; if the total spine MRI was not performed at presentation; and/or if tumour histopathology
was not obtained or was unavailable in the medical record
with exception of tumours located in the brainstem.
Imaging was performed using 1.5 or 3 T MRI units
(Siemens Avanto and Verio, Erlangen, Germany). The spinal
MRI protocol consisted of a combination of 2D and 3D MRI
sequences as follows: (1) sagittal 2D T1WþC turbo spin
echo (TSE) with fat saturation (473e543 ms repetition time
[TR], 10 ms echo time [TE], 256384 matrix, 3 mm section
thickness; 1 mm gap, average time 4 minutes 30 seconds);
(2) axial 3D T1WþC VIBE (6.3e9.9 ms TR, 2.5e4.7 ms TE, 12
ﬂip angle, 205256 matrix, 2.5e3 mm section thickness;
0 mm gap, average time 4 minutes 15 seconds); (3) sagittal
3D T2W SPACE (1,100e1,200 ms TR, 116e121 ms TE, 150
ﬂip angle, 320322 matrix, 2 mm section thickness, 0 mm
gap, average time 6 minutes 45 seconds) with sequences
performed of the upper half of the spine then and repeated
for the lower half of the spine in the order listed above for
a total imaging time of approximately 30 minutes. A standard volume of 0.1 mmol/kg of gadobenate dimeglumine

(Multihance, Bracco Diagnostics, Princeton, NJ, USA) was
administered intravenously for post-contrast imaging.
Two fellowship trained board certiﬁed neuroradiologists
(A.K., 3 years of experience and D.O., 8 years of experience)
with certiﬁcate of added qualiﬁcation (CAQ) in neuroradiology performed a retrospective individual blinded review
of all sequences from the total spine MRI for the presence or
absence of drop metastases. Drop metastasis diagnosis was
based on the reviewer’s experience and broadly deﬁned as
abnormal leptomeningeal enhancement or nodularity in
the spinal canal. The reviewers were blinded to the brain
MRI, tumour histopathology, CSF cytology, follow-up imaging, and ofﬁcial radiology report.
The reviewers were instructed to ﬁrst evaluate only the
sagittal 2D T1WþC TSE images for presence of drop metastases (yes, no, indeterminate), and subjective image
quality (ﬁve-point scale: 1 ¼ non-diagnostic, 2 ¼ below
average with artefacts affecting interpretation; 3 ¼ average
anatomical detail with minimal artefacts, 4 ¼ above average
anatomical detail without signiﬁcant artefacts; 5 ¼ excellent anatomical detail and no signiﬁcant artefacts). Next, the
reviewers evaluated the axial 3D T1WþC VIBE for the ﬁnal
diagnosis of drop metastases (yes, no, indeterminate),
subjective image quality of the axial images (as above), and
if the number of drop metastases detected increased with
addition of axial images (yes, no). Lastly, the reviewers
analysed the 3D T2W SPACE images to compare the overall
conspicuity of drop metastases to the sagittal 2D T1WþC
TSE and axial 3D T1WþC VIBE images (e.g., more conspicuous, similar conspicuity, less conspicuous, or not visible).
For all patients in whom there was a discordant diagnosis
for drop metastases, the reviewers performed a combined
review and reached a consensus diagnosis for drop metastases (yes, no, indeterminate). The interobserver agreement
between reviewers for the diagnosis of drop metastases was
calculated by using the Kappa statistic (k). A k value of
0.81e1.0 indicated excellent agreement between the two
reviewers, 0.61e0.80 indicated good agreement, 0.41e0.60
indicated moderate agreement, 0.21e0.40 indicated fair
agreement, and 0e0.20 indicated only slight agreement.
A retrospective review of each patient’s medical record
was performed to determine the age of the patient at presentation, duration of time between initial spinal MRI to a
follow-up spinal MRI (if present), and ﬁnal tumour histopathological diagnosis per surgical specimen analysis by an
experienced board-certiﬁed neuropathologist. Only those
patients with brainstem tumours did not have a ﬁnal histopathological diagnosis from a surgical specimen. All CSF
samples were obtained through a lumbar puncture and
were reviewed by an experienced board-certiﬁed cytopathologist using Diff-Quick and Papanicolau-stained SurePath slides to obtain a positive or negative CSF cytology
diagnosis. The reviewers’ consensus diagnosis for the
presence or absence of drop metastasis was compared to
the CSF cytology diagnosis to determine the false-negative
MRI rate (negative MRI/ positive CSF) and false-negative
CSF rate (negative CSF/positive MRI). A 95% conﬁdence interval (CI) for the proportion of false-negatives between
MRI and CSF cytology was obtained. McNemar’s test was
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used to compare the results of spinal MRI versus CSF
cytology, and an unpaired two-tailed t-test was used to the
subjective image quality with p<0.05 considered statistically signiﬁcant (VassarStats: Statistical Computation Web
Site, 2013, http://vassarstats.net).

Results
The mean age was 6.7 years (range 0.2e17 years). The
mean follow-up duration was 8.1 months (range 4e16
months) and no patients who had an initial negative MRI
developed drop metastases on the follow-up spinal MRI
within 6 months from the initial spinal MRI.
Results of MRI and CSF cytology for detection of drop
metastases are listed in Tables 1 and 2. A total of 14/55 patients (25%) were diagnosed with drop metastases, including
9/55 (16%) by MRI only, 2/55 (4%) by CSF cytology only, and 3/
55 (5%) with both MRI and CSF cytology. Therefore, the MRI
false-negative rate was 4% (95% CI: 1e12%) and the CSF falsenegative rate was 16% (95% CI: 9e28%). The differences between the MRI and CSF cytology false-negative rates were
not statistically signiﬁcant (p¼0.07). Representative examples are demonstrated in Figs 1e3.
The number of patients in which the 3D T1WþC VIBE
images increased the number of lesions detected was 42%
(5/12) cases. After reviewing the 3D T1WþC VIBE images,
the reviewers changed their diagnosis 22% (12/55) of the
time. Interobserver agreement improved from moderate
agreement (k ¼ 0.49) to good agreement (k ¼ 0.79)
following review of 3D T1WþC VIBE. There was similar
good agreement for imaging performed at 1.5 T (k ¼ 0.79)
compared to imaging performed at 3 T (k ¼ 0.78). Subjective
image quality assessment of the sagittal 2D T1WþC images
was 3.63 compared to 3.84 for the 3D T1WþC VIBE and the
difference was statistically signiﬁcant (p¼0.03). There was
no signiﬁcant difference in image quality for the sagittal 2D
T1WþC images or axial 3D T1WþC VIBE images performed
at 1.5 T versus 3 T (3.55 versus 3.73, p¼ 0.194; 3.77 versus
3.79, p¼0.930).
Among patients who had a ﬁnal consensus diagnosis of
drop metastases on the contrast-enhanced MRI, drop
Table 1
Detection of drop metastases with three-dimensional (3D) spinal magnetic
resonance imaging (MRI) and cerebrospinal ﬂuid (CSF) cytology.
Pathology

Patients (%)

MRI
positive (%)

CSF
positive (%)

Medulloblastoma
and PNET
Ependymoma
Brainstem tumoura
JPA
GBM
Germinoma
ATRT
Pineoblastoma
Total

16 (29%)

6 (38%)

3 (19%)

11 (20%)
9 (16%)
7 (13%)
5 (9%)
4 (7%)
2 (4%)
1 (2%)
55

2 (18%)
1 (11%)
2 (29%)
0 (0%)
0 (0%)
1 (50%)
0 (0%)
12 (22%)

2
0
0
0
0
0
0
5

(18%)
(0%)
(0%)
(0%)
(0%)
(0%)
(0%)
(9%)

PNET, primitive neuroectodermal tumor; JPA, juvenile pilocytic astrocytoma;
GBM, glioblastoma multiforme; ATRT, atypical teratoid rhabdoid tumor.
a
Brainstem tumours consisted of tectal glioma (n¼1), pontine glioma
(n¼6), and medullary glioma (n¼2).
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Table 2
Comparison of cerebrospinal ﬂuid (CSF) cytology and spinal magnetic resonance imaging (MRI) diagnosis of drop metastases.

Positive CSF cytology
Negative CSF cytology
Total

Positive MRI

Negative MRI

Total

3
9
12

2
41
43

5
50
55

metastases were detected in 83% (10/12) of these patients
on the 3D T2W SPACE images. The 3D T2W SPACE images
were considered more conspicuous (representative Figs 2
and 3) for demonstrating drop metastases in 25% (3/12) of
these cases and involved primary diagnoses of atypical
teratoid rhabdoid tumour (ATRT), medulloblastoma, and
juvenile pilocytic astrocytoma (JPA), while the remainder
were considered similar, or less conspicuous, or not visible.
Two cases in which drop metastases were not identiﬁed on
the 3D T2W SPACE images occurred in patients with
supratentorial primitive neuroectodermal tumour (PNETO)
and cerebellar medulloblastoma, with one patient having
leptomeningeal metastases coating the cauda equina and
another with tiny foci of nodular enhancement along the
cauda equina.

Discussion
Both CSF cytology and MRI spine imaging are used for
detecting drop metastases; however, neither possesses
100% accuracy.2e4 Among patients with histological proof of
leptomeningeal disease, no more than 59% demonstrate
positive post-mortem CSF cytology.7 Conversely, patients
may have positive CSF cytology without apparent abnormalities on spinal MRI. A false-negative MRI may be secondary to micrometastases, CSF ﬂow artefact obscuring a
metastasis, patient motion, or lack of identiﬁcation by the
interpreting radiologist. A spectrum from subtle to obvious
drop metastases may be encountered, as well as a wide
range of image quality, which likely represents the primary
detractors from interobserver agreement in clinical practice. Interestingly, only the spinal MRI results demonstrated
signiﬁcant correlation with patient survival in a study
comparing spinal MRI versus lumbar CSF cytology versus
intracranial CSF cytology for detection of drop metastases in
paediatric patients with medulloblastomas, supratentorial
PNET, and ependymomas.3 Therefore, MRI spine techniques
that ultimately improve the reproducibility and accuracy of
the detection of drop metastases are extremely valuable for
patient management and prognosis. In the present study,
the 3D spinal MRI sequences improved interobserver
agreement from good to nearly excellent, which may reduce
the variability of radiological diagnosis, as well as improved
image quality by reducing CSF artefacts, which allows a
radiologist to conﬁrm a drop metastasis in two orthogonal
planes of imaging, subsequently increasing the conﬁdence
in radiologist diagnosis of drop metastases.
In a large series of 106 paediatric patients with medulloblastomas and PNETs spanning nearly a 9-year period
published over 15 years ago, Fouladi et al.2 reported a false-
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Figure 1 A 7-year-old patient with a history of supratentorial PNET. (a) Sagittal 2D T1WþC with fat-saturation image demonstrates nodular
enhancement along the dorsal thoracic spinal cord suspicious for leptomeningeal metastases, which is less likely to be a CSF ﬂow artefact.
(b) Axial 3D T1WþC VIBE image demonstrates enhancing leptomeningeal nodules along the dorsal thoracic spinal cord, which are more discrete
compared to the sagittal 2D T1WþC image, and conﬁrming leptomeningeal metastases. (c) Sagittal 3D T2W SPACE image demonstrates less
conspicuous leptomeningeal nodules compared to 2D T1WþC and 3D T1WþC images.

negative CSF cytology rate of 8.5% (with a 95% upper bound
of 14.4%) and a false-negative MRI rate of 11.3% (95% upper
bound 17.7%), and concluded CSF cytology outperformed
MRI for detection of drop metastases.2 In the present study,
MRI with 2D and 3D sequences performed better than CSF
cytology, although still within the 95% CI, which may be due
to smaller sample size resulting in a wider 95% upper
bound. The present study also included a much wider
spectrum of primary paediatric brain tumour diseases, as
would be typically encountered in the general paediatric
population. One false-negative MRI occurred in a patient

with an ependymoma with positive CSF cytology. In this
patient, a follow-up MRI performed within 2 months did
not demonstrate MRI evidence of drop metastases and
follow- up CSF cytology was negative for malignancy.
Potentially, such a false-negative result may be secondary to
micrometastases. Another explanation for a false-negative
MRI result in the present study is the potential for tumour
dissemination arising from tumour resection, as CSF
cytology was obtained postoperatively. To the authors’
knowledge, no prior study has analysed the possibility of
tumour dissemination arising from surgery as a confounder
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Figure 2 An 11-year-old patient with a history of medulloblastoma. (a) Sagittal 3D T2W SPACE image demonstrates a leptomeningeal nodule
along the dorsal thoracic thecal sac. (b) Axial 3D T1WþC VIBE image demonstrates an isointense leptomeningeal nodule along dorsal thoracic
spinal cord. (c) Sagittal 2D T1WþC with fat-saturation image demonstrates subtle leptomeningeal nodular enhancement that is less conspicuous
compared to 3D T2W SPACE.

in this regard. Obtaining CSF cytology either before or after
surgery is standard practice at the authors’ institution,
which precludes eliminating this limitation from the
methodology; however, if CSF dissemination arising from
surgery is a possibility, this would suggest that the falsenegative MRI rate may be even lower. The present study

demonstrated the continued limitations of CSF cytology for
the detection of drop metastases. It is uncertain whether
the CSF obtained through lumbar puncture is a limitation of
the present study given that there are conﬂicting data
regarding whether lumbar CSF or intracranial CSF is more
reliable for diagnosis of drop metastases.3,8,9
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Figure 3 A 15-month-old patient with history of ATRT. (a) Sagittal 3D T2W SPACE image demonstrates a well-deﬁned leptomeningeal nodule
along the dorsal cervical spinal cord. (b) Axial 3D T1WþC VIBE image demonstrates a subtle leptomeningeal nodule along right dorsal cervical
spinal cord, although less conspicuous compared to 3D T2W SPACE image. (c) Sagittal 2D T1WþC with fat saturation image does not
demonstrate the leptomeningeal nodule.

As current standard of care does not include routine
resection of spinal drop metastases, the lack of histological
conﬁrmation remains a limitation for conﬁrming MRI results in this regard. A spectrum ranging from subtle to
obvious MRI ﬁndings of drop metastases in the spinal canal
may be encountered, such that a positive or negative MRI
result can depend on the conﬁdence of the interpreting
radiologist. Improvements in imaging techniques for the

diagnosis of drop metastases should be able to demonstrate
increased interobserver agreement, improve image quality,
and increase conspicuity of drop metastases. At many institutions with multidisciplinary paediatric tumour conferences, more than one radiologist may be involved in
determining the presence or absence of drop metastases
such that improvements in interobserver agreement
diminish the possibility for discordance regarding the
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diagnosis of drop metastases. The results of the present
study indicate improvement in interobserver agreement
and improved image quality when including 3D spinal MRI
sequences. To the authors’ knowledge, this research effort
represents the ﬁrst report of interobserver agreement of
radiologists in the detection of spinal drop metastases in
addition to demonstrating imaging techniques that may
improve image quality. The improvement in interobserver
agreement and increased number of drop metastases
detected with 3D sequences may likely reﬂect the
improvement in image quality resulting from CSF ﬂow
artefact reduction and the reduced section thickness.
The primary imaging artefact encountered using 3D
T1WþC VIBE is a wrap artefact at the top and bottom of the
series that can be counteracted by overlapping the coverage
in the mid-portion of the spine as well as acquiring a few
image sections above and below the desired cranial and
caudal coverage areas. An important notable difference for a
radiologist who may be inexperienced with the axial 3D
T1WþC VIBE appearance is the improved visualisation of
small vessels extending along the spinal cord surface, which
can readily be distinguished from drop metastases by their
linear, winding pattern and craniocaudal continuity. Radiologists may consider a short period of utilising both 2D and
3D sequences to develop familiarity with the increased
anatomical detail and potential imaging artefacts.
Although the 3D T2W SPACE sequence may not replace
contrast-enhanced sequences, the signiﬁcant CSF to parenchyma contrast with 3D T2W imaging provided a complementary aid in the detection of drop metastases and
improved lesion conspicuity of drop metastases compared
to contrast-enhanced imaging in a few of the present cases.
Analogous to this potential complementary role of 3D T2W
imaging for the detection of drop metastases, is the reported
detection of spinal drop metastases with diffusion-weighted
imaging.10 Diffusion-weighted imaging was not included in
the present protocol due to frequently encountered imaging
artefacts; however, this could be included if institutions are
able to perform this sequence with routine high-quality
imaging. Ultimately, the MRI sequences used for evaluation of drop metastases are impacted by the sequences
available and clinical performance including respect for
imaging time. In the authors’ experience, 3D T1WþC VIBE
can has a similar imaging duration to a conventional axial 2D
T1WþC sequence and 3D T2 SPACE can be added without
compromising image quality and radiological diagnosis.
There are some limitations to the present study. The
spinal MRI examinations of paediatric brain tumour patients were examined upon initial presentation to avoid the
potential confounding variable of radiation therapy. An
unavoidable potential limitation of this retrospective study
surrounds the unknown impact of treatment initiation (e.g.,
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steroids or chemotherapy) on the CSF cytology results.
Further evaluation of 3D MRI spine techniques in detecting
drop metastases could also be considered among patients
with recurrent tumour, prior spinal radiotherapy, and adult
patients with brain tumours. A combination of 2D and 3D
spinal imaging was chosen because of previously reported
cases of reduced conspicuity of intracranial contrastenhancing lesions in 3D imaging compared to 2D TSE
techniques, and to utilize the complementary value of both
techniques for detecting spinal drop metastases.11 Further
investigation of spinal MRIs for diagnosis of drop metastases, which only utilize 3D MRI sequences, may be helpful to
compare to the combination of 2D and 3D imaging MRI
protocol used in the present study.
In conclusion, spinal MRI examinations including 2D and
3D sequences demonstrate characteristics that may
improve radiological diagnosis of drop metastases.
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